| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.15▼ | 3.14▼ | 3.14▼ | 2.96▲ | 2.45▲ |
| MA10 | 3.15▼ | 3.13▼ | 3.09▲ | 2.60▲ | 2.17▲ |
| MA20 | 3.15▼ | 3.07▲ | 3.07▲ | 2.28▲ | 1.83▲ |
| MA50 | 3.10▲ | 3.03▲ | 2.77▲ | 2.14▲ | 1.36▲ |
| MA100 | 3.10▲ | 2.70▲ | 2.40▲ | 1.72▲ | 3.39▼ |
| MA200 | 3.00▲ | 2.34▲ | 2.17▲ | 1.37▲ | 3.35▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.000▲ | -0.013▼ | 0.117▲ | 0.129▲ |
| RSI | 48.953▼ | 56.165▲ | 60.379▲ | 78.036▲ | 76.995▲ |
| STOCH | 61.574 | 67.541 | 73.187 | 90.204▲ | 51.638 |
| WILL %R | -66.667 | -23.810▲ | -53.933 | -16.000▲ | -13.408▲ |
| CCI | -44.175 | 65.245 | 46.584 | 120.563▲ | 236.510▲ |
| ▼ GAP | $STTK Open Gap Down %2 | Set Alert |
|
Monday, December 01, 2025 12:33 PM
HC Wainwright upgrades Shattuck Labs on confidence in SL-325, a DR3 antibody aiming for stronger, durable IBD treatment amid TL1A concerns.
|
|
Friday, November 28, 2025 10:26 PM
With strong three-month performance and significant upside potential, Shattuck Labs, Inc. (NASDAQ:STTK) secures a spot on our list of the 12 hot penny stocks to invest in right now. Highlighting the ...
|
|
Tuesday, November 25, 2025 02:39 AM
Key Insights Significant control over Shattuck Labs by individual investors implies that the general public has ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/12/25 | 2.94 | 3.19 | 2.94 | 3.14 | 430,900 |
| 08/12/25 | 3.20 | 3.38 | 2.91 | 3.01 | 628,800 |
| 05/12/25 | 2.97 | 3.12 | 2.90 | 3.10 | 498,800 |
| 04/12/25 | 2.61 | 3.00 | 2.595 | 2.97 | 576,800 |
| 03/12/25 | 2.51 | 2.62 | 2.42 | 2.60 | 281,900 |
| 02/12/25 | 2.40 | 2.54 | 2.35 | 2.48 | 329,300 |
| 01/12/25 | 2.25 | 2.50 | 2.25 | 2.41 | 1,132,000 |
| 28/11/25 | 2.16 | 2.16 | 2.07 | 2.10 | 39,013 |
| 26/11/25 | 2.02 | 2.18 | 1.975 | 2.13 | 136,900 |
| 25/11/25 | 2.08 | 2.111 | 1.93 | 2.01 | 56,300 |
|
|
||||
|
|
||||
|
|